Clinical Trials Directory

Trials / Completed

CompletedNCT03068091

Assessment of Lung Movement With Computed Tomography (CT)

Assessment of Lung Movement With CT in Healthy Subjects and Patients With ILD

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
University of Missouri-Columbia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether patient with ILD have altered lung compliance on chest CT before they have macroscopic structural changes on CT.

Detailed description

Interstitial lung disease (ILD) is a group of lung disorders in which the lung tissues become inflamed and then damaged. Idiopathic Pulmonary Fibrosis (IPF) is one of the subtypes of ILD which has characteristic histological and CT features. It is well known that microscopic fibrosis occurs in the lungs of IPF patients well before the structural changes of fibrosis become apparent on CT. By combining sophisticated image analysis with CT scans obtained at full inspiration and full expiration, it may be possible to detect earlier changes of IPF than currently possible by looking at macro structural features alone. With the recent development of new therapeutics for IPF, early detection of the disease and improved monitoring of treatment efficacy will become important. Using CT to assess regional lung compliance has the potential to become an easily translated clinical tool.

Conditions

Interventions

TypeNameDescription
DEVICEChest CTInspiration and expiration chest CT
DIAGNOSTIC_TESTPulmonary Function TestingMeasure lung function

Timeline

Start date
2017-07-01
Primary completion
2018-09-30
Completion
2018-10-31
First posted
2017-03-01
Last updated
2020-05-01
Results posted
2020-05-01

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03068091. Inclusion in this directory is not an endorsement.